Pharmaceutical News

RSS

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).

7 Dec 2016

Study examines link between employment status and nonmedical use of prescription opioids

Researchers at Columbia University's Mailman School of Public Health found that employment status is a factor in nonmedical use of prescription opioids and prescription stimulants.

7 Dec 2016

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Imagine a key that opens a pin tumbler lock. A very similar key can also fit into the lock, but upside down in comparison to the first key.

6 Dec 2016

Leukaemia patients could safely reduce side effects of drug by cutting dose in half, study shows

Patients with a chronic type of leukaemia could safely reduce the side effects of life-long treatment by cutting their dose in half, according to the results of a University of Liverpool led study presented at an international conference in America this week.

6 Dec 2016

Study finds high rates of marijuana use among Baby Boomers

The recent legalization of recreational marijuana (cannabis) use in California, Colorado, and Washington reflect the sweeping changes in the attitudes and perceptions towards marijuana use in the United States.

6 Dec 2016

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Results of a new study led by Johns Hopkins researchers offer new evidence for a strong link between angiotensin receptor autoantibodies and increased risk of frailty.

6 Dec 2016

Postnova AF2000 system to assist UCL in developing novel nanoscale vehicles for drug delivery

Postnova Analytics reports on the recent investment by the Department of Chemistry at University College London in an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

6 Dec 2016

ARxIUM launches new RIVA automated IV compounding system to improve patient safety, pharmacy productivity

ARxIUM, an industry-leading developer of pharmacy automation and workflow solutions, today announced the release of its newest RIVA automated IV compounding system.

6 Dec 2016

ILC-UK urges change to eligibility guidelines to increase uptake of shingles vaccination

Responding to the news of falls in uptake of the shingles vaccination, the International Longevity Centre UK (ILC-UK) has urged a change to its eligibility guidelines.

6 Dec 2016

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.

6 Dec 2016

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Women treated with a common chemotherapy drug combination have more young eggs in their ovaries afterwards, research has found.

6 Dec 2016

Research validates effectiveness of world-first dental vaccine

A world-first vaccine developed by Melbourne scientists, which could eliminate or at least reduce the need for surgery and antibiotics for severe gum disease, has been validated by research published this weekend in a leading international journal.

5 Dec 2016

New drug treatment can override genetic fault that causes choroideremia

Researchers with funding from Fight for Sight have demonstrated that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia – a severe blinding disorder.

5 Dec 2016

CBD oil may reduce frequency and severity of seizures in patients with epilepsy, UAB study shows

Cannabidiol oil, also known as CBD oil, reduces the frequency and severity of seizures in children and adults with severe, intractable epilepsy, according to findings presented by researchers from the University of Alabama at Birmingham at the American Epilepsy Society 70th Annual Meeting.

5 Dec 2016

$Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows$

Pharmaceutical News

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

Study examines link between employment status and nonmedical use of prescription opioids

Biochemists uncover how potential diabetes drugs interact with LRH-1 protein

Leukaemia patients could safely reduce side effects of drug by cutting dose in half, study shows

Study finds high rates of marijuana use among Baby Boomers

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Postnova AF2000 system to assist UCL in developing novel nanoscale vehicles for drug delivery

ARxIUM launches new RIVA automated IV compounding system to improve patient safety, pharmacy productivity

ILC-UK urges change to eligibility guidelines to increase uptake of shingles vaccination

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Research validates effectiveness of world-first dental vaccine

New drug treatment can override genetic fault that causes choroideremia

CBD oil may reduce frequency and severity of seizures in patients with epilepsy, UAB study shows

Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows

Researchers develop portable sensor for fast, accurate assessment of blood's clotting ability

Study reveals new way to improve stability of common protein drugs

New FDA-approved drug helps patients fight against late-stage lung cancer

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

Combination of demineralized bone and gene therapy shows promise for treating pseudarthrosis

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News